Banque Cantonale Vaudoise’s Nutex Health NUTX Stock Holding History

Banque Cantonale Vaudoise’s Portfolio NUTX Stock Details NUTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-314	Closed	-$152K	–	1269
2022 Q2	$152K	Buy	+314	New	+$370K	0.01%	811

Other funds holding NUTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

EWP

Engrave Wealth Partners The Woodlands, Texas $350M AUM 13.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Banque Cantonale Vaudoise's NUTX Position: Q3 2022 in Review

Banque Cantonale Vaudoise sold out of Nutex Health (NUTX) in Q3 2022, closing a stake of 314 shares — an estimated $152K sold.

Banque Cantonale Vaudoise first reported a position in NUTX in Q2 2022 and held it in 1 quarter. The position peaked at $152K in Q2 2022. 51 funds tracked by Wall St. Rank hold NUTX as of Q3 2022.

Banque Cantonale Vaudoise reported no remaining Nutex Health position as of Q3 2022 after selling out during the quarter.
Banque Cantonale Vaudoise sold 314 Nutex Health shares in Q3 2022, an estimated $152K.
Banque Cantonale Vaudoise first reported a position in Nutex Health in Q2 2022 and held it in 1 quarter.
Banque Cantonale Vaudoise's Nutex Health position peaked at $152K in Q2 2022.
51 funds tracked by Wall St. Rank held Nutex Health as of Q3 2022.

Based on Banque Cantonale Vaudoise's 13F filing for Q3 2022, filed 17 Oct 2022.